CEA-SCAN®

(Arcitumomab)

Documentation

Patented
Approved 1996
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Imaging
Target: CD66(CEA)
Indication Category: Cancer

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA